Spire Healthcare Group PLC
SPI
ISIN GB00BNLPYF73 / Valor 24881418
Spire Healthcare Group PLC
UMushroom community rating:
About company
Spire Healthcare Group PLC is a prominent independent healthcare provider in the United Kingdom, operating a network of 39 hospitals and over 30 clinics, medical centres, and consulting rooms. The company offers a comprehensive range of surgical, medical, and diagnostic services, as well as sports medicine, physiotherapy, and rehabilitation through its brand, Perform. Established in 2007 through the acquisition of BUPA Hospitals by private equity firm Cinven, Spire has expanded its portfolio over the years, including the addition of new hospitals in Manchester and Nottingham in 2017. With a focus on capital investments in its facilities, Spire is committed to delivering high-quality care with excellent clinical outcomes and patient satisfaction. In 2021, the Group reported revenue of £1,106.2 million.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (14.08.2024):
Revenue Growth
Spire Healthcare Group PLC reported a significant increase in revenue for the year ended 31 December 2023, reaching £1,359.0 million. This represents a 13.4% growth compared to the previous year, driven by increasing demand for private healthcare services.
Operating Profit
The company achieved an operating profit of £126.2 million for FY23, marking a 32.3% increase from the prior year. This growth was delivered despite macroeconomic uncertainties and an inflationary environment.
Adjusted EBIT and EBITDA
Spire Healthcare's Adjusted EBIT rose by 23.5% to £130.4 million, while Adjusted EBITDA increased by 15.0% to £234.0 million for the year ended 31 December 2023. These improvements reflect the company's strong operational performance.
Net Bank Debt
As of 31 December 2023, Spire Healthcare Group PLC's net bank debt stood at £315.7 million, a 26.2% increase from the previous year. The net bank debt to EBITDA covenant ratio was maintained at 2.2x, consistent with the end of FY22.
Dividend Recommendation
The Board of Spire Healthcare has recommended a final dividend of 2.1 pence per ordinary share for FY23, a significant increase from the 0.5 pence per ordinary share declared in the previous year. This recommendation underscores the company's strong financial performance and confidence in future growth.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1174 M
Market cap (USD)
281,223
Daily traded volume (Shares)
2.2 / 2.165
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
